CORE
đŸ‡ºđŸ‡¦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Activity of subsequent new drugs (NDs) in post-docetaxel (DOC) failure for metastatic castration-resistant prostate cancer (mCRPC) patients (pts): A multicenter Italian experience.
Authors
Alessandro D'Angelo
Caterina Messina
+18Â more
Cinzia Ortega
Daniele Alesini
Donatello Gasparro
Enrico Campadelli
Francesco Massari
Gaetano Facchini
Giovanni Lo Re
Giuseppe Procopio
Lucia Fratino
Maddalena Donini
Marcello Tucci
Orazio Caffo
Paolo A. Zucali
Raffaele Ratta
Roberto Sabbatini
Teodoro Sava
Ugo De Giorgi
Umberto Basso
Publication date
Publisher
'American Society of Clinical Oncology (ASCO)'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
Last time updated on 25/10/2020